Table 3 Univariate and multivariate regression analyses of predictor variables for P. falciparum and P. malariae infection
Variable | n (%) | Univariate analysis | Multivariate analysis |
|---|---|---|---|
Odds ratio (CI), P value | Odds ratio (CI), P value | ||
P. falciparum positive | 84 (23.7) | Â | Â |
SCD | |||
 AA | 262 (74) | 1 | 1 |
 AC | 41 (11.6) | 1.0 (0.46–2.15), 0.99 | 0.97 (0.45–0.10), 0.93 |
 AS | 45 (12.7) | 0.77 (0.35–1.69), 0.52 | 0.70 (0.32–1.55), 0.38 |
 SS | 2 (0.6) | 3.09 (0.19–50.17), 0.43 | 2.25 (0.11–45.85), 0.60 |
HIV | |||
 Negative | 299 (85.6) | 1 | 1 |
 HIV 1 | 42 (11.9) | 1.49 (0.74–3.03), 0.27 | 1.33 (0.64–2.78), 0.45 |
 HIV 1 & 2 | 9 (2.5) | 0.95 (0.95–0.19), 0.95 | 0.93 (0.19–4.67), 0.93 |
Diabetes | |||
 Negative | 341 (96.3) | 1 | 1 |
 Positive | 13 (3.7) | 0.96 (0.26–3.58), 0.96 | 0.83 (0.22–3.15), 0.78 |
Recent anti-malarial intake | |||
 None | 250 (70.6) | 1 | 1 |
 3–6 months ago | 75 (21.2) | 0.46 (0.23-0.92), 0.03* | 0.46 (0.23–0.92), 0.03* |
 <3 months ago | 29 (8.2) | 0.56 (0.21-1.52), 0.25 | 0.50 (0.18–1.44), 0.20 |
Preventive measures | |||
 None | 16 (4.5) | 1 | 1 |
 ITN | 58 (16.4) | 0.45 (0.27–0.99), 0.04* | 0.45 (0.27–0.99), 0.04* |
 Other (mosquito spray & coil) | 280 (79.1) | 1.58 (0.25–5.48), 0.63 | 1.39 (0.17–5.23), 0.45 |
Sex | |||
 F | 314 (88.7) | 1 | 1 |
 M | 40 (11.3) | 1.08 (0.51–2.31), 0.84 | 1.23 (0.53–2.82), 0.63 |